USE OF NOREPINEPHRINE REUPTAKE INHIBITORS FOR THE TREATMENT OF COGNITIVE FAILURE
Application 770/KOLNP/2004 published 2006-04-14, filed 2004-06-07
Selective norepinephrine reuptake inhibitors, particularly atomoxetine, reboxetine and 2-alkylthio substituted phenoxyphenyl propylamines, are used for the treatment of cognitive failure, including cognitive failure due to dementia, delirium and schizophrenia (FIG.nil).
Applicant
ELI LILLY AND COMPANY.,
LILLY CORPORATE CENTER, INDIANAPOLIS, IN 46285, USA.
Inventor
1. BYMASTER, FRANKLIN, PORTER 2. GEHLERT, DONALD, RICHARD 3. MCKINZIE, DAVID, LEE 4. YANG, CHARLES, RENKIN
International Info
Classification: A61K 31/00
Publication Number: WO 03/049724
Application Date: 2002-11-27
Priority Information
60/339,174 USA 2001-12-11